La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Brain »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Brachial Plexus < Brain < Brain Chemistry  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 311.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000024 (2017) Daryl J. Wile [Canada] ; Pankaj A. Agarwal [Inde] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Katherine Dinelle [Canada] ; Elham Shahinfard [Canada] ; Nasim Vafai [Canada] ; Kazuko Hasegawa [Japon] ; Jing Zhang [États-Unis] ; Jessamyn Mckenzie [Canada] ; Nicole Neilson [Canada] ; Audrey Strongosky [États-Unis] ; Ryan J. Uitti [États-Unis] ; Mark Guttman [Canada] ; Cyrus P. Zabetian [États-Unis] ; Yu-Shin Ding [États-Unis] ; Mike Adam [Canada] ; Jan Aasly [Norvège] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A Jon Stoessl [Canada]Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
000086 (2017) Christopher R. Honey ; Clement Hamani ; Suneil K. Kalia [Canada] ; Tejas Sankar ; Marina Picillo [Canada] ; Renato P. Munhoz [Canada] ; Alfonso Fasano [Canada] ; Michel Panisset [Canada]Deep Brain Stimulation Target Selection for Parkinson's Disease.
000121 (2016) Musleh A. Algarni [Canada] ; A Jon Stoessl [Canada]The role of biomarkers and imaging in Parkinson's disease.
000137 (2016) Michel Boutin ; Ying Sun [États-Unis] ; John J. Shacka [États-Unis] ; Christiane Auray-BlaisTandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease.
000163 (2016) Anna Chang [Canada] ; Susan H. Fox [Canada]Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.
000185 (2016) Lorraine V. Kalia [Canada] ; Anthony E. Lang [Canada]Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD.
000189 (2016) Andrew D. Robertson [Canada] ; Michelle A. Messner [Canada] ; Zahra Shirzadi [Canada] ; Galit Kleiner-Fisman [Canada] ; Joyce Lee [Canada] ; Julia Hopyan [Canada] ; Anthony E. Lang [Canada] ; Sandra E. Black [Canada] ; Bradley J. Macintosh [Canada] ; Mario Masellis [Canada]Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders.
000191 (2016) Julieta E. Arena [Canada] ; A Jon Stoessl [Canada]Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
000199 (2016) Mohammed Filali [Canada] ; Robert Lalonde [France]Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP.
000279 (2016) James F M. Cornwell [États-Unis] ; Becca Franks [Canada] ; E Tory Higgins [États-Unis]Distress from Motivational Dis-integration: When Fundamental Motives Are Too Weak or Too Strong.
000306 (2016) Josie-Anne Bertrand [Canada] ; Anthony R. Mcintosh [Canada] ; Ronald B. Postuma [Canada] ; Natasha Kovacevic [Canada] ; Véronique Latreille [Canada] ; Michel Panisset [Canada] ; Sylvain Chouinard [Canada] ; Jean-François Gagnon [Canada]Brain Connectivity Alterations Are Associated with the Development of Dementia in Parkinson's Disease.
000329 (2016) Michael D. Staudt [Canada] ; Andrea R. Di Sebastiano ; Hu Xu ; Mandar Jog ; Susanne Schmid ; Paula Foster ; Matthew O. HebbAdvances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review.
000331 (2016) Daryl J. Wile [Canada] ; Katie Dinelle [Canada] ; Nasim Vafai [Canada] ; Jessamyn Mckenzie [Canada] ; Joseph K. Tsui [Canada] ; Paul Schaffer [Canada] ; Yu-Shin Ding [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A Jon Stoessl [Canada]A scan without evidence is not evidence of absence: Scans without evidence of dopaminergic deficit in a symptomatic leucine-rich repeat kinase 2 mutation carrier.
000335 (2016) Christian Duval [Canada] ; Jean-Francois Daneault [États-Unis] ; William D. Hutchison [Canada] ; Abbas F. Sadikot [Canada]A brain network model explaining tremor in Parkinson's disease.
000342 (2015) Lorraine V. Kalia [Canada] ; Suneil K. Kaliaα-Synuclein and Lewy pathology in Parkinson's disease.
000368 (2015) Jackalina M. Van Kampen [Canada] ; David C. Baranowski [Canada] ; Harold A. Robertson [Canada] ; Christopher A. Shaw [Canada] ; Denis G. Kay [Canada]The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease.
000375 (2015) Ulf Ziemann [Allemagne] ; Janine Reis [Allemagne] ; Peter Schwenkreis [Allemagne] ; Mario Rosanova [Italie] ; Antonio Strafella [Canada] ; Radwa Badawy [Australie] ; Florian Müller-Dahlhaus [Allemagne]TMS and drugs revisited 2014.
000385 (2015) Véronique Latreille [Canada] ; Julie Carrier [Canada] ; Marjolaine Lafortune [Canada] ; Ronald B. Postuma [Canada] ; Josie-Anne Bertrand [Canada] ; Michel Panisset [Canada] ; Sylvain Chouinard [Canada] ; Jean-François Gagnon [Canada]Sleep spindles in Parkinson's disease may predict the development of dementia.
000401 (2015) Yilong Ma [États-Unis] ; Tom H. Johnston [Canada] ; Shichun Peng [États-Unis] ; Chuantao Zuo [République populaire de Chine] ; James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Yihui Guan [République populaire de Chine] ; David Eidelberg [États-Unis] ; Jonathan M. Brotchie [Canada]Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET.
000410 (2015) Y. Wang [Canada] ; Z. Zhou [Canada] ; T. Leylek [Canada] ; H. Tan [Canada] ; Y. Sun [Canada] ; F E Parkinson [Canada] ; J-F Wang [Canada]Protein cysteine S-nitrosylation inhibits vesicular uptake of neurotransmitters.
000413 (2015) M. Yue [États-Unis] ; K M Hinkle [États-Unis] ; P. Davies [Royaume-Uni] ; E. Trushina [États-Unis] ; F C Fiesel [États-Unis] ; T A Christenson [États-Unis] ; A S Schroeder [États-Unis] ; L. Zhang [États-Unis] ; E. Bowles [États-Unis] ; B. Behrouz [États-Unis] ; S J Lincoln [États-Unis] ; J E Beevers [États-Unis] ; A J Milnerwood [Canada] ; A. Kurti [États-Unis] ; P J Mclean [États-Unis] ; J D Fryer [États-Unis] ; W. Springer [États-Unis] ; D W Dickson [États-Unis] ; M J Farrer [Canada] ; H L Melrose [États-Unis]Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Brain" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Brain" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Brain
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022